JBS, propensity score
Journal of Biopharmaceutical Statistics, JBiopharmStat
![Journal of Biopharmaceutical Statistics, JBiopharmStat]()
要查看或添加评论，请登录
Journal of Biopharmaceutical Statistics, JBiopharmStat的更多文章
-
JBS2024年2月24日
JBS
A basket trial design based on constrained hierarchical Bayesian model for latent subgroups: Journal of…
-
#JBS2024年2月20日
#JBS
[Special issue PRO] Considering endpoints for comparative tolerability of cancer treatments using patient report given…
4
-
#JBS2024年2月14日
#JBS
Miettinen and Nurminen score statistics revisited: Journal of Biopharmaceutical Statistics: Vol 0, No 0…
3
-
JBS2024年2月6日
JBS
A promising subgroup identification method based on a genetic algorithm for censored survival data: Journal of…
-
MMRM vs LOCF2024年2月2日
MMRM vs LOCF
Response to Comment on “Emerging insights and commentaries – MMRM vs LOCF by Naitee Ting”: Journal of Biopharmaceutical…
4
-
#JBS, #baskettrial, #decisionmaking2024年1月31日
#JBS, #baskettrial, #decisionmaking
Generalized triple outcome decision-making in basket trials: Journal of Biopharmaceutical Statistics: Vol 0, No 0…
-
#JBS, #baskettrial2024年1月23日
#JBS, #baskettrial
Generalized triple outcome decision-making in basket trials: Journal of Biopharmaceutical Statistics: Vol 0, No 0…
2
-
#JBS, #Pediacticissue2024年1月20日
#JBS, #Pediacticissue
Advancing drug development in pediatric oncology, a focus on cancer biology and targeted therapies: iMATRIX platform:…
1
-
#JBS, #timetoevent,2024年1月17日
#JBS, #timetoevent,
Bayesian phase II adaptive randomization by jointly modeling efficacy and toxicity as time-to-event outcomes: Journal…
-
#JBS, #Oncology, #delayedeffect2024年1月13日
#JBS, #Oncology, #delayedeffect
Sequential monitoring of cancer immunotherapy trial with random delayed treatment effect: Journal of Biopharmaceutical…
1
社区洞察
-
Analytical Methods DevelopmentHow do you handle method transfer and comparability studies?
-
EntrepreneurshipWhat are the most effective ways to manage innovation in a biopharmaceutical business?
-
GMPWhat are the most common pitfalls and mistakes to avoid in drug product specification development?
-
BiotechnologyYour client doubts the quality of your biopharmaceutical product. How will you address their concerns?
-
Financial ManagementHow do transfer pricing methods impact pharmaceutical companies?
-
BioengineeringHow can you ensure the safety and effectiveness of combination products during design review and approval?
-
BiotechnologyYou're in biopharmaceutical manufacturing with tight deadlines. How do you prioritize quality control tasks?
-
GMPHow do you measure change control and deviation performance?
-
GMPHow do you verify GMP equipment and methods?
-
Analytical Methods DevelopmentHow do you demonstrate analytical method equivalence for post-approval changes?
其他会员也浏览了
-
CoPay Program Optimization When Good just isn’t Good Enough
Al Kenney 4 年 -
An Unmissable Panel Discussion
Rowan Moore 7 年 -
Highlighting collaboration in Covid-19 response
Dan Spacie 4 年 -
#JBS, #timetoevent, #PETT
Journal of Biopharmaceutical Statistics, JBiopharmStat 1 年 -
#JBS, #multipleimputation
Journal of Biopharmaceutical Statistics, JBiopharmStat 2 年 -
#JBS, #dosefinding, #modelassisted
Journal of Biopharmaceutical Statistics, JBiopharmStat 1 年 -
#JBS, #Weibull, #adverseevents
Journal of Biopharmaceutical Statistics, JBiopharmStat 1 年 -
#JBS, #Bayesian, #studydesign, #Interimanalysis
Journal of Biopharmaceutical Statistics, JBiopharmStat 1 年 -
#jbs, #AE, #severity, #incidence
Journal of Biopharmaceutical Statistics, JBiopharmStat 1 年 -
#JBS, #binary, #riskratio, #riskdifference, #oddsratio
Journal of Biopharmaceutical Statistics, JBiopharmStat 2 年